478 related articles for article (PubMed ID: 30883607)
21. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
[TBL] [Abstract][Full Text] [Related]
22. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
23. [The potential of synthetic small interfering RNA-based antiviral drugs for influenza treatment].
Pashkov EA; Faizuloev EB; Svitich OA; Sergeev OV; Zverev VV
Vopr Virusol; 2020 Sep; 65(4):182-190. PubMed ID: 33533221
[TBL] [Abstract][Full Text] [Related]
24. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
[TBL] [Abstract][Full Text] [Related]
25. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.
Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF
Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988
[TBL] [Abstract][Full Text] [Related]
27. The highly pathogenic H5N1 influenza A virus down-regulated several cellular MicroRNAs which target viral genome.
Wang R; Zhang YY; Lu JS; Xia BH; Yang ZX; Zhu XD; Zhou XW; Huang PT
J Cell Mol Med; 2017 Nov; 21(11):3076-3086. PubMed ID: 28609011
[TBL] [Abstract][Full Text] [Related]
28. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
Su WC; Hsu SF; Lee YY; Jeng KS; Lai MM
J Virol; 2015 Nov; 89(22):11245-55. PubMed ID: 26311876
[TBL] [Abstract][Full Text] [Related]
29. Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.
Jacob A; Sood R; Chanu KhV; Bhatia S; Khandia R; Pateriya AK; Nagarajan S; Dimri U; Kulkarni DD
Microb Pathog; 2016 Feb; 91():35-40. PubMed ID: 26639679
[TBL] [Abstract][Full Text] [Related]
30. The host interactome of influenza virus presents new potential targets for antiviral drugs.
Shaw ML
Rev Med Virol; 2011 Nov; 21(6):358-69. PubMed ID: 21823192
[TBL] [Abstract][Full Text] [Related]
31. Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
Ma C; Li F; Musharrafieh RG; Wang J
Antiviral Res; 2016 Sep; 133():62-72. PubMed ID: 27478032
[TBL] [Abstract][Full Text] [Related]
32. Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication.
Sui HY; Zhao GY; Huang JD; Jin DY; Yuen KY; Zheng BJ
PLoS One; 2009 May; 4(5):e5671. PubMed ID: 19479060
[TBL] [Abstract][Full Text] [Related]
33. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication.
Han J; Perez JT; Chen C; Li Y; Benitez A; Kandasamy M; Lee Y; Andrade J; tenOever B; Manicassamy B
Cell Rep; 2018 Apr; 23(2):596-607. PubMed ID: 29642015
[TBL] [Abstract][Full Text] [Related]
35. G-Protein-Coupled Receptor and Ion Channel Genes Used by Influenza Virus for Replication.
Orr-Burks N; Murray J; Todd KV; Bakre A; Tripp RA
J Virol; 2021 Apr; 95(9):. PubMed ID: 33536179
[TBL] [Abstract][Full Text] [Related]
36. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
Zhou K; He H; Wu Y; Duan M
J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
[TBL] [Abstract][Full Text] [Related]
37. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
38. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
Chen SC; Jeng KS; Lai MMC
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
[TBL] [Abstract][Full Text] [Related]
39. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
Blyth GA; Chan WF; Webster RG; Magor KE
J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
[TBL] [Abstract][Full Text] [Related]
40. Drosophila RNAi screen identifies host genes important for influenza virus replication.
Hao L; Sakurai A; Watanabe T; Sorensen E; Nidom CA; Newton MA; Ahlquist P; Kawaoka Y
Nature; 2008 Aug; 454(7206):890-3. PubMed ID: 18615016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
